oncolex logo
Utskriftsdato 22.9.2020

Referanser til strupekreft

  1. Cancer in Norway 2018, Cancer Registry of Norway, Institute of Population-based Research. Oslo, Norway
  2. Thawley SE, Panje WR, Batsakis JG, Lindberg WB. Comprehensive Management of Head and Neck Tumors. 2. opplag. W.B. Philadelphia: Saunders Company, 1999 
  3. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss, 2002
  4. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH. TNM Atlas. 5. ed. Heidelberg: Springer, 2005
  5. Janfaza P, Nadol JB, Galla R, Fabien RL. Surgical anatomy of the head and neck. Lipincott, Williams & Wilkins, 2001
  6. Boysen M, Lövdal O, Tausjö J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992; 28: 455-60
  7. Boysen M, Loven JØ. Second malignant neoplasms in patients with head and neck squamous cell carcinomas. Acta Oncol. 1993; 32: 283-288
  8. Pedersen E, Høgetveit AC, Andersen Å. Cancer of respiratory organs among workers at a nickel refinery in Norway. Int J Cancer 1973; 12 (1): 32-41
  9. Mork J, Møller B, Glattre E. Familial risk in head and neck squamous cell carcinoma diagnosed before the age of 45: a population based study. Oral Oncol 1999; 35 (4):360-7
  10. Brøndbo K, Boysen M, Natvig K. Laserkirurgi ved larynxcancer (T1a glottis). Tidsskrift  Nor lægeforening 1999; 117: 4070-1
  11. Mahler V, Brøndbo K, Boysen M. Radiotherapy or Co2 laser surgery as treatment of T1a glottic carcinoma? Eur Arch Otolaryngol. In press 2010.
  12. Vermund H, Boysen M, Brandenburg J H, Evensen J, Jacobsen AB et al. Primary irrradiation, Surgery or Combined Therapy in Squamous Cell Carcinoma of the Larynx. Acta Oncol. 1990; 29 (4):485–503.
  13. Vermund H, Boysen M, Evensen JF, Jacobsen AB, Natvig K et al. Recurrence after different primary treatment for cancer of the supraglottic larynx. Acta Oncol 1998; 37 (2):167–173.
  14. Abenstein H, Nordgren M, Boysen M, Jannert M, SIlander E et al. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope 2005; 115 (12):2183–2192.
  15. Boysen M. Squamous cell carcinoma of the head and neck in the elderly. The open Otolaryngology Journal. In press. 2010.
  16. Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New Engl J Med 2006;354:567-78

  17. Vermorken JB, Trigo J, Hitt R et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum- based therapy. J Clin Oncol 2007;25:2171-7.